Literature DB >> 19287958

Functional characterization of p53 in nasopharyngeal carcinoma by stable shRNA expression.

Yi Sun1, Hong Yi, Yixuan Yang, Yanhui Yu, Yongmei Ouyang, Fang Yang, Zhiqiang Xiao, Zhuchu Chen.   

Abstract

Nasopharyngeal carcinoma (NPC) is a high-incidence malignancy in Southern China and Southeast Asia. Although mutation of p53 tumor-suppressor gene is a rare event in NPC, NPC has a high frequency of overexpressed/accumulated p53 protein, which was reported to be dysfunction or inactivation in most of NPC. We report here a functional characterization of p53 in an undifferentiated NPC cell line CNE2. To elucidate the biological function of p53, we employed the RNA interference (RNAi) approach to knockdown the endogenously expressed p53 in CNE2 cells. Interestingly, suppression of p53 expression in CNE2 cells was associated with significant down-regulation of p21WAF1/CIP1 expression and decreased HDM2 protein level in both steady state and genotoxic stress induced by ionizing radiation (IR). Consistent with these biochemical data were the accelerated cell cycle progression and the increased proliferation rate, suggesting that p53 retained growth inhibitory activity in CNE2 cells. Indeed, down-regulation of p53 in CNE2 enhanced the ability of CNE2 cells to grow anchorage-independently in vitro and to develop tumors in vivo. Together with the radioresistance acquired by CNE2sip53 cells, our data indicate that in contrast to a previous study, p53 in this NPC cell line remains functional, which may have an important therapeutical implication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287958     DOI: 10.3892/ijo_00000227

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics.

Authors:  Gu-Qing Zeng; Pang-Fei Zhang; Xingming Deng; Feng-Lei Yu; Cui Li; Yan Xu; Hong Yi; Mao-Yu Li; Rong Hu; Jian-Hong Zuo; Xin-Hui Li; Xun-Xun Wan; Jia-Quan Qu; Qiu-Yan He; Jian-Huang Li; Xu Ye; Yu Chen; Jiao-Yang Li; Zhi-Qiang Xiao
Journal:  Mol Cell Proteomics       Date:  2012-01-31       Impact factor: 5.911

2.  Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma.

Authors:  Lili Guo; Min Tang; Lifang Yang; Lanbo Xiao; Ann M Bode; Lili Li; Zigang Dong; Ya Cao
Journal:  Int J Mol Med       Date:  2012-01-17       Impact factor: 4.101

3.  Oncogene mutational profile in nasopharyngeal carcinoma.

Authors:  Zi-Chen Zhang; Sha Fu; Fang Wang; Hai-Yun Wang; Yi-Xin Zeng; Jian-Yong Shao
Journal:  Onco Targets Ther       Date:  2014-03-20       Impact factor: 4.147

4.  Inhibition of STAT1 sensitizes radioresistant nasopharyngeal carcinoma cell line CNE-2R to radiotherapy.

Authors:  Song Qu; Ya Guo; Shi-Ting Huang; Xiao-Dong Zhu
Journal:  Oncotarget       Date:  2017-07-29

5.  Identifying novel genes and chemicals related to nasopharyngeal cancer in a heterogeneous network.

Authors:  Zhandong Li; Lifeng An; Hao Li; ShaoPeng Wang; You Zhou; Fei Yuan; Lin Li
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

6.  MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.

Authors:  Zhen Zheng; Jia-Quan Qu; Hong-Mei Yi; Xu Ye; Wei Huang; Ta Xiao; Jiao-Yang Li; Yuan-Yuan Wang; Juan Feng; Jin-Feng Zhu; Shan-Shan Lu; Hong Yi; Zhi-Qiang Xiao
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.